About Us
Valo Health is a technology company applying human and machine intelligence to accelerate the creation of life-changing medical treatments. At the core of this vision is Valo’s computational platform: an end-to-end, integrated drug discovery and development engine that is being built from the ground up.
Valo hires the best and gives them first-class training and support. We approach our work fearlessly, learn quickly, improve constantly, and celebrate our wins. A centerpiece of our culture is our commitment to inclusion across race, gender, age, religion, identity, and experience. Diversity fuels the Valo experience and drives us every day. We strive to create an inclusive workplace that cultivates bold innovation through collaboration and empowers our people to unleash their full potential.
As Associate Director of Machine Learning in Epidemiology and Patient Data Products, you will lead groundbreaking research that is revolutionizing drug discovery. Our innovative platform leverages advanced computational techniques to accelerate the development of new medicines. You will lead a team of data scientists at the intersection of AI capability innovation and implementing machine learning tools to solve real patient problems that have significant impacts on global health. You will own the team’s strategic vision and collaborate with patient data, computational biology and engineering product leaders to align generative AI initiatives with patient needs.
A successful candidate is passionate about leading high-impact teams, navigates ambiguous problems--right-sizing complex computational tasks, and delivers innovative machine learning/AI results to external stakeholders on time.
Valo Health, LLC (“Valo”) is a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence-driven computation. As a digitally native company, Valo aims to fully integrate human-centric data across the entire drug development life cycle into a single unified architecture, thereby accelerating the discovery and development of life-changing drugs while simultaneously reducing costs, time, and failure rates. The company’s Opal Computational Platform™ is an integrated set of capabilities designed to transform data into valuable insights that may accelerate discoveries and enable Valo to advance a robust pipeline of programs across cardiovascular metabolic renal, oncology, and neurodegenerative diseases. Founded by Flagship Pioneering and headquartered in Lexington, MA, Valo also has offices in New York, NY. To learn more, visit www.valohealth.com.
Accenture Argentina
PwC
Concentrix
GK Software SE
Zillow